Bausch + Lomb eyes AU$1.2 billion in IPO
Ophthalmic giant Bausch + Lomb (B+L), which is being spun-off from its parent as a pure-play eye health company, has ...
Tag: IPO
Eyecare spin-off Bausch + Lomb files for IPO
Almost 18 months since its parent company announced Bausch + Lomb (B+L) would be spun off as a pure-play eye ...
Tax credit strengthens Opthea’s balance sheet; follows AU$175m IPO on US exchange
Melbourne biopharmaceutical company Opthea has received an $8.5 million research and development (R&D) tax credit from the Australian tax authority ...